ArticleHeliyon2022

A PDX model combined with CD-DST assay to evaluate the antitumor properties of KRpep-2d and oxaliplatin in KRAS (G12D) mutant colorectal cancer.

Wuguo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.